Market Overview:
The global COVID-19 drug API market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of COVID-19, rising demand for novel therapeutics, and growing investments by pharmaceutical companies in R&D for the development of new drugs. The global COVID-19 drug API market is segmented on the basis of type, application, and region. On the basis of type, it is divided into hydroxychloroquine, chloroquine phosphate, and others. Chloroquine phosphate held a major share of the global COVID-19 drug API market in 2017 owing to its high efficacy against SARS CoV 2 virus strains. On the basis of application, it is segmented into tablets and injections. Injectables are expected to grow at a higher CAGR during the forecast period as they offer better patient compliance than oral formulations do. Geographically speaking, North America held a dominant share of 43% in 2017 followed by Europe with 31%. Asia Pacific is projected to be fastest growing region with a CAGR close to XX%.
Product Definition:
The COVID-19 Drug API is a protein that is used to help create a vaccine for the coronavirus. The protein helps to create an immunity to the virus, so that if someone is infected, they will be less likely to develop serious symptoms.
Hydroxychloroquine:
Hydroxychloroquine, also known as hydroxychloroquine sulfate or hydroxychloroquine citrate, is an immunosuppressive drug with anti-viral properties. It was first synthesized in the early 1950s and has been used to treat rheumatoid arthritis and lupus since then.
Chloroquine Phosphate:
Chloroquine phosphate is an antimicrobial drug used for the treatment of malaria and other diseases caused by P. falciparum and P. vivax species of the protozoan parasite. It works by inhibiting the synthesis of erythrocyte pigment which results in reduced blood volume, low hemoglobin level, and impaired respiration rate leading to death of parasites in host cells via lysis or autolysis.
Application Insights:
In terms of application, the global drug API market is categorized into tablet, injection and others. The other applications include inhalation powder for asthma inhalers and liquid for nebulizers. In terms of revenue, the injection segment dominated the overall industry in 2017 owing to high product demand in this application.
The tablet segment is expected to witness significant growth over the forecast period due to increasing product usage as a tableting agent or alone as an antacid. Hydroxychloroquine tablets are used for treating symptoms of malaria such as anemia, skin rashes and fever among others which makes it highly beneficial across all age groups especially in low-income countries where malaria is prevalent most severely (Anon., 2012).
Regional Analysis:
North America dominated the global market in 2018 owing to the presence of a large number of manufacturers and suppliers. The region is expected to maintain its dominance over the forecast period due to factors such as high disposable income, favorable government initiatives for early diagnosis and treatment, availability of effective healthcare infrastructure, and high awareness levels among people.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increasing COVID-19 positive cases in countries such as India & China. In addition, growing medical tourism industry in these countries can also be attributed for an increase in demand for API manufacturing services from this region. Moreover, economic development coupled with improvement in healthcare facilities will boost regional product demand further driving CAGR higher than other regions during the forecast years.
The European market was valued at USD X billion (EUR 1.4 billion)in 2018.
Growth Factors:
- Increasing prevalence of COVID-19 and other respiratory diseases: The increasing prevalence of COVID-19 and other respiratory diseases is expected to drive the growth of the COVID-19 drug API market.
- Rising demand for novel therapeutics: The rising demand for novel therapeutics is expected to drive the growth of the COVID-19 drug API market.
- Growing investment in R&D activities: The growing investment in R&D activities is expected to drive the growth of the COVID-19 drug API market.
- Technological advancements: Technological advancements are anticipated to fuel the growth of this market during forecast period 2019–2025 owing to their ability to improve product quality and efficiency while reducing production costs simultaneously, thereby resulting in increased profitability margins for manufacturers operating in this space over traditional methods employed currently across various geographies globally including Asia Pacific, North America, Europe, Latin America, and Rest Of World (ROW). 5) Emergence Of Contract Manufacturing Organizations (CMOs): With a large number of contract manufacturing organizations mushrooming globally with specific focus on biologics & vaccines manufacturing capabilities; it has become easier for small molecule manufacturers as well as biotech companies seeking faster time-to-market solutions or those wanting access into new markets without having significant infrastructure investments/dedicated resources themselves – To outsource portions or all their manufacturing needs which will indirectly fuel overall CMO business volumes but also help meet unmet
Scope Of The Report
Report Attributes
Report Details
Report Title
COVID-19 Drug API Market Research Report
By Type
Hydroxychloroquine, Chloroquine Phosphate, Others
By Application
Tablet, Injection
By Companies
Shanghai Zhongxi Sunve Pharma Co., Ltd., Cinkate, Fuan Pharmaceutical Group, Wuhan Wuyao Pharmaceutical Co., Ltd, Shenhua Pharmaceutical Co., Ltd, Chongqing Kangle Pharmaceutical Co., Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
175
Number of Tables & Figures
123
Customization Available
Yes, the report can be customized as per your need.
Global COVID-19 Drug API Market Report Segments:
The global COVID-19 Drug API market is segmented on the basis of:
Types
Hydroxychloroquine, Chloroquine Phosphate, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tablet, Injection
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Shanghai Zhongxi Sunve Pharma Co., Ltd.
- Cinkate
- Fuan Pharmaceutical Group
- Wuhan Wuyao Pharmaceutical Co., Ltd
- Shenhua Pharmaceutical Co., Ltd
- Chongqing Kangle Pharmaceutical Co., Ltd.
Highlights of The COVID-19 Drug API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hydroxychloroquine
- Chloroquine Phosphate
- Others
- By Application:
- Tablet
- Injection
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the COVID-19 Drug API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
COVID-19 is a drug API that is being developed by Novartis. It is a novel, small molecule inhibitor of the COVID virus.
Some of the key players operating in the covid-19 drug api market are Shanghai Zhongxi Sunve Pharma Co., Ltd., Cinkate, Fuan Pharmaceutical Group, Wuhan Wuyao Pharmaceutical Co., Ltd, Shenhua Pharmaceutical Co., Ltd, Chongqing Kangle Pharmaceutical Co., Ltd..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 COVID-19 Drug API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 COVID-19 Drug API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 COVID-19 Drug API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the COVID-19 Drug API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global COVID-19 Drug API Market Size & Forecast, 2018-2028
4.5.1 COVID-19 Drug API Market Size and Y-o-Y Growth
4.5.2 COVID-19 Drug API Market Absolute $ Opportunity
Chapter 5 Global COVID-19 Drug API Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 COVID-19 Drug API Market Size Forecast by Type
5.2.1 Hydroxychloroquine
5.2.2 Chloroquine Phosphate
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global COVID-19 Drug API Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 COVID-19 Drug API Market Size Forecast by Applications
6.2.1 Tablet
6.2.2 Injection
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global COVID-19 Drug API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 COVID-19 Drug API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America COVID-19 Drug API Analysis and Forecast
9.1 Introduction
9.2 North America COVID-19 Drug API Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America COVID-19 Drug API Market Size Forecast by Type
9.6.1 Hydroxychloroquine
9.6.2 Chloroquine Phosphate
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America COVID-19 Drug API Market Size Forecast by Applications
9.10.1 Tablet
9.10.2 Injection
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe COVID-19 Drug API Analysis and Forecast
10.1 Introduction
10.2 Europe COVID-19 Drug API Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe COVID-19 Drug API Market Size Forecast by Type
10.6.1 Hydroxychloroquine
10.6.2 Chloroquine Phosphate
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe COVID-19 Drug API Market Size Forecast by Applications
10.10.1 Tablet
10.10.2 Injection
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific COVID-19 Drug API Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific COVID-19 Drug API Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific COVID-19 Drug API Market Size Forecast by Type
11.6.1 Hydroxychloroquine
11.6.2 Chloroquine Phosphate
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific COVID-19 Drug API Market Size Forecast by Applications
11.10.1 Tablet
11.10.2 Injection
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America COVID-19 Drug API Analysis and Forecast
12.1 Introduction
12.2 Latin America COVID-19 Drug API Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America COVID-19 Drug API Market Size Forecast by Type
12.6.1 Hydroxychloroquine
12.6.2 Chloroquine Phosphate
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America COVID-19 Drug API Market Size Forecast by Applications
12.10.1 Tablet
12.10.2 Injection
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) COVID-19 Drug API Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) COVID-19 Drug API Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) COVID-19 Drug API Market Size Forecast by Type
13.6.1 Hydroxychloroquine
13.6.2 Chloroquine Phosphate
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) COVID-19 Drug API Market Size Forecast by Applications
13.10.1 Tablet
13.10.2 Injection
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 COVID-19 Drug API Market: Competitive Dashboard
14.2 Global COVID-19 Drug API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Shanghai Zhongxi Sunve Pharma Co., Ltd.
14.3.2 Cinkate
14.3.3 Fuan Pharmaceutical Group
14.3.4 Wuhan Wuyao Pharmaceutical Co., Ltd
14.3.5 Shenhua Pharmaceutical Co., Ltd
14.3.6 Chongqing Kangle Pharmaceutical Co., Ltd.
